These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34462784)

  • 1. Validation of ZMYND8 as a new treatment target in hepatocellular carcinoma.
    Choi S; Lee KW; Koh HH; Park S; Yeo SY; Joh JW; Choi MS; Kim SH; Park CK; Ha SY
    J Cancer Res Clin Oncol; 2021 Dec; 147(12):3517-3534. PubMed ID: 34462784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZMYND8 promotes the growth and metastasis of hepatocellular carcinoma by promoting HK2-mediated glycolysis.
    Dou C; Mo H; Chen T; Liu J; Zeng Y; Li S; Guo C; Zhang C
    Pathol Res Pract; 2021 Mar; 219():153345. PubMed ID: 33517164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of LZAP as a new candidate tumor suppressor in hepatocellular carcinoma.
    Zhao JJ; Pan K; Li JJ; Chen YB; Chen JG; Lv L; Wang DD; Pan QZ; Chen MS; Xia JC
    PLoS One; 2011; 6(10):e26608. PubMed ID: 22028922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target.
    Chen DT; Pan JH; Chen YH; Xing W; Yan Y; Yuan YF; Zeng WA
    Br J Anaesth; 2019 Jun; 122(6):e157-e167. PubMed ID: 30915986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High ADAM8 expression is associated with poor prognosis in patients with hepatocellular carcinoma.
    Zhang Y; Tan YF; Jiang C; Zhang K; Zha TZ; Zhang M
    Pathol Oncol Res; 2013 Jan; 19(1):79-88. PubMed ID: 22965687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromodomain-containing protein 7 (BRD7) as a potential tumor suppressor in hepatocellular carcinoma.
    Chen CL; Wang Y; Pan QZ; Tang Y; Wang QJ; Pan K; Huang LX; He J; Zhao JJ; Jiang SS; Zhang XF; Zhang HX; Zhou ZQ; Weng de S; Xia JC
    Oncotarget; 2016 Mar; 7(13):16248-61. PubMed ID: 26919247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1.
    Kan H; Huang Y; Li X; Liu D; Chen J; Shu M
    Oncotarget; 2016 Mar; 7(12):14336-49. PubMed ID: 26893361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insight into BIRC3: A novel prognostic indicator and a potential therapeutic target for liver cancer.
    Fu PY; Hu B; Ma XL; Yang ZF; Yu MC; Sun HX; Huang A; Zhang X; Wang J; Hu ZQ; Zhou CH; Tang WG; Ning R; Xu Y; Zhou J
    J Cell Biochem; 2019 Apr; 120(4):6035-6045. PubMed ID: 30368883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EYA4 serves as a prognostic biomarker in hepatocellular carcinoma and suppresses tumour angiogenesis and metastasis.
    Gu F; Yuan S; Liu L; Zhu P; Yang Y; Pan Z; Zhou W
    J Cell Mol Med; 2019 Jun; 23(6):4208-4216. PubMed ID: 30957411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIP6 promotes tumorigenic capability through regulating FOXC1 in hepatocellular carcinoma.
    Wang F; Zhang B; Xu X; Zhu L; Zhu X
    Pathol Res Pract; 2020 Apr; 216(4):152850. PubMed ID: 32046874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HUS1 checkpoint clamp component (HUS1) is a potential tumor suppressor in primary hepatocellular carcinoma.
    Zhou ZQ; Zhao JJ; Chen CL; Liu Y; Zeng JX; Wu ZR; Tang Y; Zhu Q; Weng DS; Xia JC
    Mol Carcinog; 2019 Jan; 58(1):76-87. PubMed ID: 30182378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
    Liu T; Chen J; Xiao S; Lei X
    Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis.
    Ha SY; Kim JH; Yang JW; Kim J; Kim B; Park CK
    Cancer Res Treat; 2016 Jul; 48(3):1065-73. PubMed ID: 26511806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of ORAOV1 as a new treatment target in hepatocellular carcinoma.
    Ha SY; Yeo SY; Lee KW; Kim SH
    J Cancer Res Clin Oncol; 2021 Feb; 147(2):423-433. PubMed ID: 33161447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uridine-cytidine kinase 2 upregulation predicts poor prognosis of hepatocellular carcinoma and is associated with cancer aggressiveness.
    Huang S; Li J; Tam NL; Sun C; Hou Y; Hughes B; Wang Z; Zhou Q; He X; Wu L
    Mol Carcinog; 2019 Apr; 58(4):603-615. PubMed ID: 30556610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
    Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
    EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
    Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
    BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and prognostic significance of epithelial tissue-specific transcription factor ESE3 in hepatocellular carcinoma.
    Lyu Z; Ma M; Xu Y; Wang X; Zhu Y; Ren W; Li T
    Int J Clin Oncol; 2020 Jul; 25(7):1334-1345. PubMed ID: 32347431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.